The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
Abstract Background Coronavirus disease 2019 (COVID-19) has infected people in many countries worldwide. Discovering an effective treatment for this disease, particularly in severe cases, has become the subject of intense scientific investigation. Therefore, the objective of this study was to evalua...
Main Authors: | Naser Gharebaghi, Rahim Nejadrahim, Seyed Jalil Mousavi, Seyyed-Reza Sadat-Ebrahimi, Reza Hajizadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12879-020-05507-4 |
Similar Items
-
A retrospective study of children with multisystemi nflammatory syndrome and intravenous immunoglobulin treatment
by: Kolla Sravani, et al.
Published: (2022-01-01) -
Injection of intravenous immunoglobulin (IVIg) for the treatment of Coronavirus induced cytokine storm
by: Farahnoosh Farnood, et al.
Published: (2022-12-01) -
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
by: V. A. Lazanovich, et al.
Published: (2014-08-01) -
IMMUNOREGULATORY EFFECTS OF INTRAVENOUS IMMUNOGLOBULINS
by: S. A. Sel'kov, et al.
Published: (2014-07-01) -
Side Effects of Intravenous Immunoglobulin Treatment in Neurological Disorders
by: Buket Oflazoğlu, et al.
Published: (2006-02-01)